Article
Dissecting diffuse large B-cell lymphoma heterogeneity: New insights from a state-specific molecular characterisation.
Clinical and translational medicine - 1 Aug 2026
Papotti Robel, Vit Filippo, Bittolo Tamara, Pozzo Federico, Bettelli Stefania, Pozzi Samantha, Braglia Luca, Forti Elisa, Di Napoli Arianna, Cox M Christina, Tadmor Tamar, Musto Pellegrino, Flenghi Leonardo, Quintini Martina, Mansueto Giovanna R, Galimberti Sara, Donati Valentina, Spina Michele, Zamò Alberto, Rosenwald Andreas, Bomben Riccardo, Sacchi Stefano, Gattei Valter
Abstract excerpt
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease. METHODS: In this study, we analysed a real-world cohort of 178 newly diagnosed DLBCL patients homogeneously treated with R-CHOP-like regimens, integrating RNA sequencing, targeted mutational profiling and digital deconvolution using the EcoTyper algorithm. RESULTS: Five malignant B-cell states (S1-S5) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
